In mice immunized through the administration of recombinant SARS-CoV-2 spike protein antigens, the decline in anti-COVID-19 antibodies caused by OxS and SOD decreased upon virus re-exposure, and the activation of the JAK2/STAT1 pathway was efficiently counteracted by upregulating SOD production [48]. The gene discussed is SOD1; the disease is COVID-19.